The proposal would let the FDA hold off on enforcement for certain peptides. FDA staff scientists found none proven safe or effective, and CSPI is pushing back.
Recap by typeshit. Full story at Ars Technica.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The Telangana Drugs Control Administration issued a strict warning over unapproved weight-loss drugs and peptides being sold online in the Indian state.
Close to three in four patients had trouble taking their GLP-1 consistently, and researchers say cost may be pushing people to quit early.
Wellness experts are giving fasting fresh attention while GLP-1 drugs make eating more complicated, especially for women.
Loading…